APO Research, Inc.

APO RESEARCH · REPORT

Primaquine Phosphate Tablets

Selected research

Market Structure

Global Primaquine Phosphate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Primaquine Phosphate Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Primaquine Phosphate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Primaquine Phosphate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Primaquine Phosphate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Primaquine Phosphate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Primaquine Phosphate Tablets include Chongqing Kerui Pharmaceutical, Shandong Xinhua Pharmaceutical, Southwest Pharmaceutical, Shanghai Pharmaceuticals, Sanofi, Chengdu Diao Pharmaceutical Group and Teva Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Primaquine Phosphate Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Primaquine Phosphate Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Primaquine Phosphate Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Primaquine Phosphate Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Primaquine Phosphate Tablets Segment by Company

Chongqing Kerui Pharmaceutical

Shandong Xinhua Pharmaceutical

Southwest Pharmaceutical

Shanghai Pharmaceuticals

Sanofi

Chengdu Diao Pharmaceutical Group

Teva Pharmaceuticals

Primaquine Phosphate Tablets Segment by Type

Original Drug

Generic Drug

Primaquine Phosphate Tablets Segment by Application

Hospital

Clinic

Others

Primaquine Phosphate Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Primaquine Phosphate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Primaquine Phosphate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Primaquine Phosphate Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Primaquine Phosphate Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Primaquine Phosphate Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Primaquine Phosphate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Primaquine Phosphate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Primaquine Phosphate Tablets Industry Trends Table 2. Primaquine Phosphate Tablets Industry Drivers Table 3. Primaquine Phosphate Tablets Industry Opportunities and Challenges Table 4. Primaquine Phosphate Tablets Industry Restraints Table 5. Global Primaquine Phosphate Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Primaquine Phosphate Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Primaquine Phosphate Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Primaquine Phosphate Tablets Sales Market Share by Manufacturers Table 9. Global Primaquine Phosphate Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Primaquine Phosphate Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Primaquine Phosphate Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Primaquine Phosphate Tablets Manufacturers, Product Type & Application Table 13. Global Primaquine Phosphate Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Primaquine Phosphate Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Original Drug Table 17. Major Manufacturers of Generic Drug Table 18. Global Primaquine Phosphate Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Primaquine Phosphate Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Primaquine Phosphate Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Primaquine Phosphate Tablets Sales Market Share by Type (2021-2026) Table 22. Global Primaquine Phosphate Tablets Sales Market Share by Type (2027-2032) Table 23. Global Primaquine Phosphate Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Primaquine Phosphate Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Primaquine Phosphate Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Primaquine Phosphate Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Primaquine Phosphate Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Others Table 31. Global Primaquine Phosphate Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Primaquine Phosphate Tablets Sales by Application (2021-2026) & (K Units) Table 33. Global Primaquine Phosphate Tablets Sales by Application (2027-2032) & (K Units) Table 34. Global Primaquine Phosphate Tablets Sales Market Share by Application (2021-2026) Table 35. Global Primaquine Phosphate Tablets Sales Market Share by Application (2027-2032) Table 36. Global Primaquine Phosphate Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Primaquine Phosphate Tablets Revenue by Application (2021-2026) & (K Units) Table 38. Global Primaquine Phosphate Tablets Revenue by Application (2027-2032) & (K Units) Table 39. Global Primaquine Phosphate Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Primaquine Phosphate Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Primaquine Phosphate Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Primaquine Phosphate Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Primaquine Phosphate Tablets Sales Market Share by Region (2021-2026) Table 44. Global Primaquine Phosphate Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Primaquine Phosphate Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Primaquine Phosphate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Primaquine Phosphate Tablets Sales by Country (2021-2026) & (K Units) Table 48. North America Primaquine Phosphate Tablets Sales by Country (2027-2032) & (K Units) Table 49. Europe Primaquine Phosphate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Primaquine Phosphate Tablets Sales by Country (2021-2026) & (K Units) Table 51. Europe Primaquine Phosphate Tablets Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Primaquine Phosphate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Primaquine Phosphate Tablets Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Primaquine Phosphate Tablets Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Primaquine Phosphate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Primaquine Phosphate Tablets Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Primaquine Phosphate Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Primaquine Phosphate Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Primaquine Phosphate Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Primaquine Phosphate Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Primaquine Phosphate Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Primaquine Phosphate Tablets Revenue Market Share by Region (2027-2032) Table 63. Chongqing Kerui Pharmaceutical Company Information Table 64. Chongqing Kerui Pharmaceutical Business Overview Table 65. Chongqing Kerui Pharmaceutical Primaquine Phosphate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Chongqing Kerui Pharmaceutical Primaquine Phosphate Tablets Product Portfolio Table 67. Chongqing Kerui Pharmaceutical Recent Development Table 68. Shandong Xinhua Pharmaceutical Company Information Table 69. Shandong Xinhua Pharmaceutical Business Overview Table 70. Shandong Xinhua Pharmaceutical Primaquine Phosphate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Shandong Xinhua Pharmaceutical Primaquine Phosphate Tablets Product Portfolio Table 72. Shandong Xinhua Pharmaceutical Recent Development Table 73. Southwest Pharmaceutical Company Information Table 74. Southwest Pharmaceutical Business Overview Table 75. Southwest Pharmaceutical Primaquine Phosphate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Southwest Pharmaceutical Primaquine Phosphate Tablets Product Portfolio Table 77. Southwest Pharmaceutical Recent Development Table 78. Shanghai Pharmaceuticals Company Information Table 79. Shanghai Pharmaceuticals Business Overview Table 80. Shanghai Pharmaceuticals Primaquine Phosphate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Shanghai Pharmaceuticals Primaquine Phosphate Tablets Product Portfolio Table 82. Shanghai Pharmaceuticals Recent Development Table 83. Sanofi Company Information Table 84. Sanofi Business Overview Table 85. Sanofi Primaquine Phosphate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sanofi Primaquine Phosphate Tablets Product Portfolio Table 87. Sanofi Recent Development Table 88. Chengdu Diao Pharmaceutical Group Company Information Table 89. Chengdu Diao Pharmaceutical Group Business Overview Table 90. Chengdu Diao Pharmaceutical Group Primaquine Phosphate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Chengdu Diao Pharmaceutical Group Primaquine Phosphate Tablets Product Portfolio Table 92. Chengdu Diao Pharmaceutical Group Recent Development Table 93. Teva Pharmaceuticals Company Information Table 94. Teva Pharmaceuticals Business Overview Table 95. Teva Pharmaceuticals Primaquine Phosphate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Teva Pharmaceuticals Primaquine Phosphate Tablets Product Portfolio Table 97. Teva Pharmaceuticals Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Primaquine Phosphate Tablets Distributors List Table 101. Primaquine Phosphate Tablets Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Primaquine Phosphate Tablets Product Image Figure 2. Global Primaquine Phosphate Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Primaquine Phosphate Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Primaquine Phosphate Tablets Sales (2021-2032) & (K Units) Figure 5. Global Primaquine Phosphate Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Primaquine Phosphate Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Original Drug Image Figure 9. Generic Drug Image Figure 10. Global Primaquine Phosphate Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Primaquine Phosphate Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Primaquine Phosphate Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Primaquine Phosphate Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Primaquine Phosphate Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Primaquine Phosphate Tablets Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Others Image Figure 19. Global Primaquine Phosphate Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Primaquine Phosphate Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Primaquine Phosphate Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Primaquine Phosphate Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Primaquine Phosphate Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Primaquine Phosphate Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Primaquine Phosphate Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Primaquine Phosphate Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Primaquine Phosphate Tablets Sales Market Share by Country (2021-2032) Figure 39. China Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Primaquine Phosphate Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Primaquine Phosphate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Primaquine Phosphate Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Primaquine Phosphate Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Primaquine Phosphate Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Primaquine Phosphate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Primaquine Phosphate Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Primaquine Phosphate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Primaquine Phosphate Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Primaquine Phosphate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Primaquine Phosphate Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Primaquine Phosphate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Primaquine Phosphate Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Primaquine Phosphate Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Chongqing Kerui Pharmaceutical
  • Shandong Xinhua Pharmaceutical
  • Southwest Pharmaceutical
  • Shanghai Pharmaceuticals
  • Sanofi
  • Chengdu Diao Pharmaceutical Group
  • Teva Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Primaquine Phosphate Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Primaquine Phosphate Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Primaquine Phosphate Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Primaquine Phosphate Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Primaquine Phosphate Tablets Market Dynamics
  1. 2.1 Primaquine Phosphate Tablets Industry Trends
  2. 2.2 Primaquine Phosphate Tablets Industry Drivers
  3. 2.3 Primaquine Phosphate Tablets Industry Opportunities and Challenges
  4. 2.4 Primaquine Phosphate Tablets Industry Restraints
3 Primaquine Phosphate Tablets Market by Manufacturers
  1. 3.1 Global Primaquine Phosphate Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Primaquine Phosphate Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Primaquine Phosphate Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Primaquine Phosphate Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Primaquine Phosphate Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Primaquine Phosphate Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Primaquine Phosphate Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Primaquine Phosphate Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Primaquine Phosphate Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Primaquine Phosphate Tablets Tier 1, Tier 2, and Tier 3
4 Primaquine Phosphate Tablets Market by Type
  1. 4.1 Primaquine Phosphate Tablets Type Introduction
  2. 4.1.1 Original Drug
  3. 4.1.2 Generic Drug
  4. 4.2 Global Primaquine Phosphate Tablets Sales by Type
  5. 4.2.1 Global Primaquine Phosphate Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Primaquine Phosphate Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Primaquine Phosphate Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Primaquine Phosphate Tablets Revenue by Type
  9. 4.3.1 Global Primaquine Phosphate Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Primaquine Phosphate Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Primaquine Phosphate Tablets Revenue Market Share by Type (2021-2032)
5 Primaquine Phosphate Tablets Market by Application
  1. 5.1 Primaquine Phosphate Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Primaquine Phosphate Tablets Sales by Application
  6. 5.2.1 Global Primaquine Phosphate Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Primaquine Phosphate Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Primaquine Phosphate Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Primaquine Phosphate Tablets Revenue by Application
  10. 5.3.1 Global Primaquine Phosphate Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Primaquine Phosphate Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Primaquine Phosphate Tablets Revenue Market Share by Application (2021-2032)
6 Global Primaquine Phosphate Tablets Sales by Region
  1. 6.1 Global Primaquine Phosphate Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Primaquine Phosphate Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Primaquine Phosphate Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Primaquine Phosphate Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Primaquine Phosphate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Primaquine Phosphate Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Primaquine Phosphate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Primaquine Phosphate Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Primaquine Phosphate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Primaquine Phosphate Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Primaquine Phosphate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Primaquine Phosphate Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Primaquine Phosphate Tablets Revenue by Region
  1. 7.1 Global Primaquine Phosphate Tablets Revenue by Region
  2. 7.1.1 Global Primaquine Phosphate Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Primaquine Phosphate Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Primaquine Phosphate Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Primaquine Phosphate Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Primaquine Phosphate Tablets Revenue (2021-2032)
  8. 7.2.2 North America Primaquine Phosphate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Primaquine Phosphate Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Primaquine Phosphate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Primaquine Phosphate Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Primaquine Phosphate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Primaquine Phosphate Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Primaquine Phosphate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqing Kerui Pharmaceutical
  2. 8.1.1 Chongqing Kerui Pharmaceutical Company Information
  3. 8.1.2 Chongqing Kerui Pharmaceutical Business Overview
  4. 8.1.3 Chongqing Kerui Pharmaceutical Primaquine Phosphate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chongqing Kerui Pharmaceutical Primaquine Phosphate Tablets Product Portfolio
  6. 8.1.5 Chongqing Kerui Pharmaceutical Recent Developments
  7. 8.2 Shandong Xinhua Pharmaceutical
  8. 8.2.1 Shandong Xinhua Pharmaceutical Company Information
  9. 8.2.2 Shandong Xinhua Pharmaceutical Business Overview
  10. 8.2.3 Shandong Xinhua Pharmaceutical Primaquine Phosphate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shandong Xinhua Pharmaceutical Primaquine Phosphate Tablets Product Portfolio
  12. 8.2.5 Shandong Xinhua Pharmaceutical Recent Developments
  13. 8.3 Southwest Pharmaceutical
  14. 8.3.1 Southwest Pharmaceutical Company Information
  15. 8.3.2 Southwest Pharmaceutical Business Overview
  16. 8.3.3 Southwest Pharmaceutical Primaquine Phosphate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Southwest Pharmaceutical Primaquine Phosphate Tablets Product Portfolio
  18. 8.3.5 Southwest Pharmaceutical Recent Developments
  19. 8.4 Shanghai Pharmaceuticals
  20. 8.4.1 Shanghai Pharmaceuticals Company Information
  21. 8.4.2 Shanghai Pharmaceuticals Business Overview
  22. 8.4.3 Shanghai Pharmaceuticals Primaquine Phosphate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Pharmaceuticals Primaquine Phosphate Tablets Product Portfolio
  24. 8.4.5 Shanghai Pharmaceuticals Recent Developments
  25. 8.5 Sanofi
  26. 8.5.1 Sanofi Company Information
  27. 8.5.2 Sanofi Business Overview
  28. 8.5.3 Sanofi Primaquine Phosphate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Primaquine Phosphate Tablets Product Portfolio
  30. 8.5.5 Sanofi Recent Developments
  31. 8.6 Chengdu Diao Pharmaceutical Group
  32. 8.6.1 Chengdu Diao Pharmaceutical Group Company Information
  33. 8.6.2 Chengdu Diao Pharmaceutical Group Business Overview
  34. 8.6.3 Chengdu Diao Pharmaceutical Group Primaquine Phosphate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Chengdu Diao Pharmaceutical Group Primaquine Phosphate Tablets Product Portfolio
  36. 8.6.5 Chengdu Diao Pharmaceutical Group Recent Developments
  37. 8.7 Teva Pharmaceuticals
  38. 8.7.1 Teva Pharmaceuticals Company Information
  39. 8.7.2 Teva Pharmaceuticals Business Overview
  40. 8.7.3 Teva Pharmaceuticals Primaquine Phosphate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Teva Pharmaceuticals Primaquine Phosphate Tablets Product Portfolio
  42. 8.7.5 Teva Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Primaquine Phosphate Tablets Value Chain Analysis
  2. 9.1.1 Primaquine Phosphate Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Primaquine Phosphate Tablets Production Mode & Process
  6. 9.2 Primaquine Phosphate Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Primaquine Phosphate Tablets Distributors
  9. 9.2.3 Primaquine Phosphate Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.